scholarly journals Does a one hour educational class improve compliance of chlorhexidine gluconate baths prior to operation?

2017 ◽  
Vol 3 (3) ◽  
pp. 5
Author(s):  
Joseph I. Levieddin ◽  
Kevin K. Chen ◽  
Kelvin Kim ◽  
Ran Schwarzkopf

Background: Surgical site infections (SSIs) continue to be a major contributor to morbidity and mortality post-operatively. One of the treatments used to prevent such infections is chlorhexidine gluconate (CHG) baths prior to surgery. An obstacle to using CHG as a pre operative preventative measure to infection has been the low patient compliance rates. Our study aimed to analyze whether an educational class explaining the proper usage of CHG prior to the surgery date will improve patient compliance.Methods: We evaluated two different groups. One group consisted of patients who were scheduled for total joint arthroplasty (TJA) and attended an educational class in addition to receiving the standard preoperative protocol explaining the proper application of CHG. A second group consisted of subjects undergoing any other type of surgery but was not offered the additional educational class.Results: Subjects undergoing TJA had a higher compliance rate than all other surgeries (95.8% and 77.8% respectively; p < .001). Interestingly, throughout time, the effectiveness of the educational class to improve compliance also improved (from 90.9% in the first month to 100% in the final month; p < .001).Discussion: The addition of an educational class to the standard preoperative educational protocol significantly improved patient compliance to the preoperative application of CHG in TJA Patients, and increasingly so overtime. This suggests the importance of proper patient education in the prevention of costly comorbidities such as infection.Conclusions: The use of instructional classes may be useful for improving compliance to patient protocols prior to undergoing surgery. Further research is needed to fully assess the benefits of educational classes and their correlation to patient compliance.

1993 ◽  
Vol 30 (3) ◽  
pp. 292-301 ◽  
Author(s):  
Earlene T. Paynter ◽  
Beth M. Wilson ◽  
William J. Jordan

A cleft palate team's prescribed regimen requires prompt and continued compliance to meet the objectives of the clinical management and to achieve the best clinical results for the patient. In a previous study (Paynter et al., 1990), we reported an overall compliance rate of 64% for patients seen by a cleft palate team during its first 8 years of operation. After the study, changes in the team's operational procedures were made in an attempt to provide better service, improve patient compliance, and improve the efficiency of the clinic. The purposes of the current clinical investigation were to determine the degree of compliance with recommendations made by the cleft palate team for the patients seen during the four years after the implementation of the changes and to identify variables that interfered with compliance. A subject was defined as the person(s) who could best respond to questions concerning the management of the team's patient. Each subject was interviewed using a questionnaire based on the Health Belief Model (Becker et al., 1977). The mean patient compliance rate was 82%. Using Jones and Caldwell's (1981) classification, 56.7% of the patients were classified as compilers, 40% as partial compilers, and 3.3% as noncompliers. Compliance with specific recommendations ranged from 58 to 100%. No specific variable was found to interfere with compliance.


2015 ◽  
Vol 37 (3) ◽  
pp. 254-259 ◽  
Author(s):  
Charles E. Edmiston ◽  
Candace J. Krepel ◽  
Maureen P. Spencer ◽  
Alvaro A. Ferraz ◽  
Gary R. Seabrook ◽  
...  

OBJECTIVESurgical site infections (SSIs) are responsible for significant morbidity and mortality. Preadmission skin antisepsis, while controversial, has gained acceptance as a strategy for reducing the risk of SSI. In this study, we analyze the benefit of an electronic alert system for enhancing compliance to preadmission application of 2% chlorhexidine gluconate (CHG).DESIGN, SETTING, AND PARTICIPANTSFollowing informed consent, 100 healthy volunteers in an academic, tertiary care medical center were randomized to 5 chlorhexidine gluconate (CHG) skin application groups: 1, 2, 3, 4, or 5 consecutive applications. Participants were further randomized into 2 subgroups: with or without electronic alert. Skin surface concentrations of CHG (μg/mL) were analyzed using a colorimetric assay at 5 separate anatomic sites.INTERVENTIONPreadmission application of chlorhexidine gluconate, 2%RESULTSMean composite skin surface CHG concentrations in volunteer participants receiving EA following 1, 2, 3, 4, and 5 applications were 1,040.5, 1,334.4, 1,278.2, 1,643.9, and 1,803.1 µg/mL, respectively, while composite skin surface concentrations in the no-EA group were 913.8, 1,240.0, 1,249.8, 1,194.4, and 1,364.2 µg/mL, respectively (ANOVA, P<.001). Composite ratios (CHG concentration/minimum inhibitory concentration required to inhibit the growth of 90% of organisms [MIC90]) for 1, 2, 3, 4, or 5 applications using the 2% CHG cloth were 208.1, 266.8, 255.6, 328.8, and 360.6, respectively, representing CHG skin concentrations effective against staphylococcal surgical pathogens. The use of an electronic alert system resulted in significant increase in skin concentrations of CHG in the 4- and 5-application groups (P<.04 and P<.007, respectively).CONCLUSIONThe findings of this study suggest an evidence-based standardized process that includes use of an Internet-based electronic alert system to improve patient compliance while maximizing skin surface concentrations effective against MRSA and other staphylococcal surgical pathogens.Infect. Control Hosp. Epidemiol. 2016;37(3):254–259


2020 ◽  
Vol 2 (01) ◽  
pp. 21-35
Author(s):  
Pius A. L. Berek ◽  
Yati Afiyanti

Hypertensi as a one of non-communicable diseases is need of serious attention and dealt with " nation-wide " given the high prevalence and usually people do not realize that he was suffering from hypertension. Generally only known when they come for treatment to the health service because of illness or other complaints, so hypertension is often known as " the silent killer ". Patient compliance in undergoing hypertension treatment is also a determinant that affects the control of patient's blood pressure . The most important main determinant The effect on adherence to take antihypertensive medication is long suffered from hypertension. This study aims to develop theoretical concepts about strategies to improve patient compliance in self-care for hypertensive patients both pharmacologically and non-pharmacologically. The study design using qualitatively with five participants and purposive sampling. From the results of the study, six themes were obtained : experience of adherence to control, experience of handling symptoms and complications,  experience of taking medication adherence, experience of adherence to managing diets, lack of adherence to exercise, and obstacles to adherence . It is recommended that hypertensive patients can improve compliance for routine antihypertensive drug consumption by making simple schedules and enhancing their self-concept.


2020 ◽  
Vol 20 (2) ◽  
pp. 167-174
Author(s):  
Ilo Dicko ◽  
Yaya Ibrahim Coulibaly ◽  
Modibo Sangaré ◽  
Bismark Sarfo ◽  
Priscillia Awo Nortey

Background: Lymphatic filariasis (LF) is a parasitic disease that has been targeted for elimination through the Mass Drug Administration (MDA.) Although the MDA started in the Ankobra community in Ghana in 2000, LF prevalence as reported in 2014 was relatively high (4.5%). Non-compliance to the MDA has been associated with the persistent LF prevalence in endemic regions. Objective: This study determined the factors associated with the non-compliance to the MDA among patients living in the Ankobra community, Ghana. Methods: A cross-sectional study using a one-stage cluster sampling method was used to collect data between June and July, 2017 in Ankobra. Questionnaires were used to collect data from health workers, the MDA drug distributors and study participants in Ankobra. Data analysis was performed using STATA 14. Logistic regression was used to measure the degree of association between the dependent (non-compliance) and independent variables. Non-compliance rate was defined as the percentage of individuals who self-reported that they did not actually swallow the drugs provided during the MDA. Results: The MDA coverage and non-compliance rates were 73.5% (147/200) and 33.33% (49/147) respectively. The main reason for non-compliance was fear of drug adverse events (75.51%, 37/49). Thought of “not being susceptible to LF” was significantly associated with the non-compliance (aOR= 2.83, [CI= 1.15, 6.98]). Conclusion: Health education about the susceptibility of residents getting LF disease in endemic community must be intensified to improve compliance to MDA medication ingestion and thus meet the Global Elimination of Lymphatic Filariasis by 2020.


2020 ◽  
Vol 18 ◽  
pp. 191-196
Author(s):  
Mark A. Snyder ◽  
Alexandra N. Sympson ◽  
Steven J. Wurzelbacher ◽  
Po-Han Brian Chen ◽  
Frank R. Ernst

2020 ◽  
Vol 9 (6) ◽  
pp. 1988
Author(s):  
Julia Mitschke ◽  
Stefanie Anna Peikert ◽  
Kirstin Vach ◽  
Eberhard Frisch

The main objective of this study is to present patient compliance rates and influential factors for regular attendance in a systematic implant aftercare program (Supportive Implant Therapy; SIT) within a 10-year observation period. From 2005 to 2008, we identified 233 patients with 524 implants and implant-supported restorations at the study center. They had been instructed to attend an SIT program with 3-month recall intervals. A 2019 clinical prospective cohort study on 10-year compliance rates was performed. Data were assessed yearly in regression analyses to identify influential factors. Noncompliance rates increased during the period (4.8%, year 1; 39.7%, year 10). Total noncompliance was observed in four patients (1.7%) with 10 implants. “Age,” “Gender,” “Diabetes”, and “Surgical case complexity” showed no correlation with patient compliance. “Smoking” and “Cardiovascular diseases” significantly influenced patients in one of ten years, while “Number of implants per patient”, “Type of implant-supported prostheses”, and “Pre-existing experience in a prophylaxis program” reached significance after several years. When patients with implant-supported restorations are strongly recommended and frequently remotivated to comply with an SIT program with 3-month recall, an approximately 60% compliance rate after 10 years is achievable. Previous prophylaxis program experience, increased number of implants per patient, and removable implant-supported prostheses may be strong influential factors for increased patient compliance.


Sign in / Sign up

Export Citation Format

Share Document